BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents. 2008

Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Graduate Institute of Chinese Pharmaceutical Sciences, Taichung, Taiwan, R.O.C. jclien@mail.cmu.edu.tw

In continuing search for novel antiplatelet agents, the highly potent agent 2-chloro-3-methoxycarbonylethylcarboxamido-1,4-naphthoquinone 2 was selected as lead compound. Structure-activity relationships in this series were examined. Some of these compounds showed significant antiplatelet activities. Further studies on the action mechanism showed that 2-acetamido-3-chloro-1,4-naphthoquinone 4 has a direct inhibitory action on cytosolic phospholipase A(2) (cPLA(2)) activity in platelets.

UI MeSH Term Description Entries
D009285 Naphthoquinones Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. Naphthalenediones,Naphthazarins,Naphthoquinone
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Synthesis and antiplatelet, antiinflammatory and antiallergic activities of 2,3-disubstituted 1,4-naphthoquinones.
June 1996, Chemical & pharmaceutical bulletin,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents.
March 2009, European journal of medicinal chemistry,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Synthesis and evaluation of 2-phenylamino-1,4-naphthoquinones derivatives as potential hypoglycaemic agents.
January 2022, Brazilian journal of biology = Revista brasleira de biologia,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
[Lipophilic naphthols and 1,4-naphthoquinones as inhibitors of prostaglandin synthesis. 6. Study of 1,4-naphthoquinones].
January 1984, Arzneimittel-Forschung,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Synthesis of chiral 2,3-disubstituted 1,4-diazabicyclo[2.2.2]octane derivatives.
April 2015, The Journal of organic chemistry,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Synthesis of new 2-alkylmercapto-1,4-naphthoquinones as antimetabolites of coenzyme Q and as antitumor agents.
January 1978, Acta pharmaceutica Suecica,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Synthesis of 2,5-disubstituted-1,4-benzoquinone derivatives as potential antimicrobial and cytotoxic agents.
December 1998, Archiv der Pharmazie,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as potential antitumor agents.
March 2004, Bioorganic & medicinal chemistry,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
2,3-Disubstituted 1,6-naphthyridines as potential diuretic agents.
July 1973, Journal of medicinal chemistry,
Jin-Cherng Lien, and Chi-Rei Wu, and Mann-Jen Hour, and Li-Jiau Huang, and Tur-Fu Huang, and Sheng-Chu Kuo
Synthesis of 2,3-diaziridinyl-1,4-naphthoquinone sulfonate derivatives as potential antineoplastic agents.
July 1989, Journal of medicinal chemistry,
Copied contents to your clipboard!